share_log

UnitedHealth | 10-Q: Q2 2024 Earnings Report

UnitedHealth | 10-Q: Q2 2024 Earnings Report

聯合健康 | 10-Q：2024財年二季報
美股SEC公告 ·  2024/08/10 04:15

Moomoo AI 已提取核心訊息

UnitedHealth Group reported Q2 2024 revenues of $98.9 billion, up 6% year-over-year, with consolidated earnings from operations of $7.9 billion compared to $8.1 billion in Q2 2023. The quarter was impacted by the Change Healthcare cyberattack, resulting in $776 million in direct response costs and $334 million in business disruption impacts at Optum Insight.UnitedHealthcare revenues grew 5% to $73.9 billion, serving 1.6 million more people domestically, though earnings declined 8% to $4 billion due to Medicare Advantage funding reductions and cyberattack-related costs. Optum revenues increased 12% to $62.9 billion, with Optum Health up 13% and Optum Rx up 13%, while Optum Insight revenue decreased 3% due to cyberattack disruptions.The company recorded a $1.2 billion loss related to South American subsidiaries held for sale in Q2, including $867 million in foreign currency translation losses. Medical care ratio increased to 85.1% from 83.2% last year. The company maintained its strong liquidity position with $26.3 billion in cash and cash equivalents as of June 30, 2024.
UnitedHealth Group reported Q2 2024 revenues of $98.9 billion, up 6% year-over-year, with consolidated earnings from operations of $7.9 billion compared to $8.1 billion in Q2 2023. The quarter was impacted by the Change Healthcare cyberattack, resulting in $776 million in direct response costs and $334 million in business disruption impacts at Optum Insight.UnitedHealthcare revenues grew 5% to $73.9 billion, serving 1.6 million more people domestically, though earnings declined 8% to $4 billion due to Medicare Advantage funding reductions and cyberattack-related costs. Optum revenues increased 12% to $62.9 billion, with Optum Health up 13% and Optum Rx up 13%, while Optum Insight revenue decreased 3% due to cyberattack disruptions.The company recorded a $1.2 billion loss related to South American subsidiaries held for sale in Q2, including $867 million in foreign currency translation losses. Medical care ratio increased to 85.1% from 83.2% last year. The company maintained its strong liquidity position with $26.3 billion in cash and cash equivalents as of June 30, 2024.
聯合健康集團報告2024年第二季度營業收入爲989億，同比增長6%，運營合併收益爲79億，而2023年第二季度爲81億。本季度受到Change Healthcare網絡攻擊的影響，導致直接響應成本達到77600萬，Optum Insight的業務中斷影響爲33400萬。聯合健康的營業收入增長5%，達到739億，服務國內多了160萬人，但由於醫療保險優先計劃資金削減和網絡攻擊相關費用，收益下降8%，爲40億。Optum的營業收入增長12%，達到629億，Optum Health增長13%，Optum Rx增長13%，而由於網絡攻擊導致的中斷，Optum Insight的營業收入下降3%。該公司在第二季度錄得與待售南美子公司相關的12億損失，包括86700萬的外匯翻譯損失。醫療保健比率從去年的83.2%上升至85.1%。截至2024年6月30日，該公司保持強勁的流動性，現金及現金等價物爲263億。
聯合健康集團報告2024年第二季度營業收入爲989億，同比增長6%，運營合併收益爲79億，而2023年第二季度爲81億。本季度受到Change Healthcare網絡攻擊的影響，導致直接響應成本達到77600萬，Optum Insight的業務中斷影響爲33400萬。聯合健康的營業收入增長5%，達到739億，服務國內多了160萬人，但由於醫療保險優先計劃資金削減和網絡攻擊相關費用，收益下降8%，爲40億。Optum的營業收入增長12%，達到629億，Optum Health增長13%，Optum Rx增長13%，而由於網絡攻擊導致的中斷，Optum Insight的營業收入下降3%。該公司在第二季度錄得與待售南美子公司相關的12億損失，包括86700萬的外匯翻譯損失。醫療保健比率從去年的83.2%上升至85.1%。截至2024年6月30日，該公司保持強勁的流動性，現金及現金等價物爲263億。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Alignment Healthcare
    ALHC
    -- 18.300
    信諾
    CI
    -- 325.040
    聯合健康
    UNH
    -- 516.040
    Elevance Health
    ELV
    -- 432.000
    Molina Healthcare
    MOH
    -- 322.850
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    中概股財報季火熱：驚喜盈利能否延續漲勢？
    1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？ 展开
    中國兩會：會議前後股票價格變動的關鍵要點